Panagora Asset Management Inc Adverum Biotechnologies, Inc. Transaction History

Panagora Asset Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 13, 2018	SELL	$4.5 - $7.6 $44,446 - $75,065	-9,877 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$5.3 - $6.9 $11,776 - $15,331	2,222 Added 29.03%	9,877 $52,000
Q1 2018 May 15, 2018	SELL	$3.65 - $7.95 $301,271 - $656,193	-82,540 Reduced 91.51%	7,655 $44,000
Q4 2017 Feb 14, 2018	BUY	$2.85 - $3.95 $15,116 - $20,950	5,304 Added 6.25%	90,195 $316,000
Q3 2017 Nov 14, 2017	BUY	$2.45 - $3.65 $207,982 - $309,852	84,891	84,891 $310,000

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $471M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.